Audio

Florian Thomas, MD, and Adrian Hepner, MD, cover the basics of the degenerative nerve disorder.

The study author joins to highlight new ADA 2021 findings showing rivaroxaban's benefit for a subpopulation of diabetic patients.

Stephen Russell, MD, talks about promising new data that has the potential to provide a breakthrough for treating the most common mutation of the rare genetic eye disease.

Both the Mediterranean Diet and the Specific Carbohydrate diet achieved nearly 50% symptomatic remission in patients with IBD.

Viloxazine was approved in April by the FDA for pediatric ADHD patients between 6-17 years old.

The National Institutes of Health expert and research joins to discuss the evolving understanding of vaping devices and effects.

Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of dermatology.

Jordana Hoppe, MD, discusses the burden of cystic fibrosis on infants and children.

The Duke investigators return to discuss the pivotal study of rivaroxaban in peripheral artery disease.

The SGLT-2 inhibitor drug class is expanding into treatment indications experts could not have predicted. Learn how DAPA-HF contributed to the understanding of dapagliflozin.

The first episode of the Heart Trials podcast series focuses on new ACC 2021 research into aspirin dosages for reduced cardiovascular event risk.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

A podcast interview with study author Paul Yang, MD, PhD, on the current research and future implementation of the agent.

Rebecca Kazin, MD, offers some insight into her cosmetic dermatology practices, including a new hair product that she developed.

A trio of experts from the Cleveland Clinic join Dr. Rizzo for a talk on lung transplant trends and challenges in the US.

Ennis James, MD, discusses the challenges and lingering questions associated with sarcoidosis

CDC tuberculosis lead Dr. Phillip LoBue joins to discuss the past and present issues of the disease, in time for TB Awareness Day on March 24.

Eric Wallace, MD, discusses Anderson-Fabry disease and the difficulties associated with screening, testing, and treatment.

A look back on key moments from Episode 1 of the Rare Disease Report podcast —featuring Kim Smith-Whitley, MD.

Valerie Callender, MD, draws on her experiences in clinical practice to discuss cosmetic dermatology care practices and the challenges of this past year.

In this first episode, Kim Smith-Whitley, MD, discusses the history, presentations, and research status of sickle cell disease.

In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations.

A conversation with an expert virologist and public health advocate on the scientific and societal machinations of COVID-19 vaccination.

Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious.

The University of Chicago hypertension expert discusses new ADA recommendations for cardiovascular risk management.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

In this episode of Derm Discussions, Peter Lio, MD, discusses the difficulties treating itch as well as alternative—and perhaps surprising—therapeutic options.

The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.

The last episode of 2020 caps advances and ongoing research into the most burdensome chronic respiratory disease in the US.

Edmund Tsui, MD, talks the new AAO 2020 virtual format as well as presentations that have particularly caught his attention.